22-26465579-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022081.6(HPS4):​c.707-28T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.887 in 1,582,382 control chromosomes in the GnomAD database, including 625,664 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.84 ( 54152 hom., cov: 31)
Exomes 𝑓: 0.89 ( 571512 hom. )

Consequence

HPS4
NM_022081.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.491

Publications

9 publications found
Variant links:
Genes affected
HPS4 (HGNC:15844): (HPS4 biogenesis of lysosomal organelles complex 3 subunit 2) This gene encodes a protein component of biogenesis of lysosome-related organelles complexes (BLOC). BLOC complexes are important for the formation of endosomal-lysosomal organelles such as melanosomes and platelet dense granules. Mutations in this gene result in subtype 4 of Hermansky-Pudlak syndrome, a form of albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012]
HPS4 Gene-Disease associations (from GenCC):
  • Hermansky-Pudlak syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Hermansky-Pudlak syndrome with pulmonary fibrosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but is likely benign (scored 3 / 10, using the threshold of <=3). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-26465579-A-G is Benign according to our data. Variant chr22-26465579-A-G is described in ClinVar as Benign. ClinVar VariationId is 261538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.902 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HPS4NM_022081.6 linkc.707-28T>C intron_variant Intron 9 of 13 ENST00000398145.7 NP_071364.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HPS4ENST00000398145.7 linkc.707-28T>C intron_variant Intron 9 of 13 1 NM_022081.6 ENSP00000381213.2 Q9NQG7-1

Frequencies

GnomAD3 genomes
AF:
0.839
AC:
127486
AN:
152012
Hom.:
54141
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.709
Gnomad AMI
AF:
0.832
Gnomad AMR
AF:
0.758
Gnomad ASJ
AF:
0.877
Gnomad EAS
AF:
0.851
Gnomad SAS
AF:
0.903
Gnomad FIN
AF:
0.965
Gnomad MID
AF:
0.908
Gnomad NFE
AF:
0.908
Gnomad OTH
AF:
0.853
GnomAD2 exomes
AF:
0.861
AC:
215418
AN:
250248
AF XY:
0.873
show subpopulations
Gnomad AFR exome
AF:
0.705
Gnomad AMR exome
AF:
0.673
Gnomad ASJ exome
AF:
0.877
Gnomad EAS exome
AF:
0.854
Gnomad FIN exome
AF:
0.964
Gnomad NFE exome
AF:
0.907
Gnomad OTH exome
AF:
0.882
GnomAD4 exome
AF:
0.892
AC:
1276076
AN:
1430252
Hom.:
571512
Cov.:
24
AF XY:
0.895
AC XY:
638781
AN XY:
713764
show subpopulations
African (AFR)
AF:
0.704
AC:
23068
AN:
32788
American (AMR)
AF:
0.687
AC:
30675
AN:
44666
Ashkenazi Jewish (ASJ)
AF:
0.874
AC:
22668
AN:
25944
East Asian (EAS)
AF:
0.849
AC:
33521
AN:
39482
South Asian (SAS)
AF:
0.913
AC:
78145
AN:
85586
European-Finnish (FIN)
AF:
0.959
AC:
50526
AN:
52672
Middle Eastern (MID)
AF:
0.907
AC:
5159
AN:
5686
European-Non Finnish (NFE)
AF:
0.904
AC:
979786
AN:
1084034
Other (OTH)
AF:
0.884
AC:
52528
AN:
59394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
6524
13049
19573
26098
32622
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20644
41288
61932
82576
103220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.838
AC:
127548
AN:
152130
Hom.:
54152
Cov.:
31
AF XY:
0.839
AC XY:
62435
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.709
AC:
29379
AN:
41454
American (AMR)
AF:
0.758
AC:
11573
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.877
AC:
3046
AN:
3472
East Asian (EAS)
AF:
0.851
AC:
4384
AN:
5154
South Asian (SAS)
AF:
0.903
AC:
4361
AN:
4828
European-Finnish (FIN)
AF:
0.965
AC:
10233
AN:
10606
Middle Eastern (MID)
AF:
0.905
AC:
266
AN:
294
European-Non Finnish (NFE)
AF:
0.908
AC:
61755
AN:
68028
Other (OTH)
AF:
0.849
AC:
1794
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
990
1981
2971
3962
4952
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
886
1772
2658
3544
4430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.875
Hom.:
11204
Bravo
AF:
0.815
Asia WGS
AF:
0.844
AC:
2936
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hermansky-Pudlak syndrome 4 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
12
DANN
Benign
0.65
PhyloP100
0.49
BranchPoint Hunter
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213583; hg19: chr22-26861545; COSMIC: COSV61105165; COSMIC: COSV61105165; API